Skip to main content

Table 3 Logistic regression models comparing the prevalence of sequelae and persistent symptoms (SPS) in patients hospitalised due to COVID-19 compared with patients hospitalised due to other causes (reference group). Multivariate models included sex, age, ICU admission and comorbidities as covariates

From: Long COVID 12 months after discharge: persistent symptoms in patients hospitalised due to COVID-19 and patients hospitalised due to other causes—a multicentre cohort study

SPS1

OR

95%CI

Any SPS

1.13

0.85 to 1.51

General/systemic SPS

0.82

0.56 to 1.19

 Fatigue

0.57

0.36 to 0.90

 Muscle or joint pain

0.82

0.52 to 1.30

Respiratory SPS

1.47

1.00 to 2.16

 Dyspnoea

1.13

0.76 to 1.68

Neurological SPS

2.20

1.21 to 3.96

 Headache

1.28

0.52 to 3.13

 Sensitivity disorders

0.82

0.31 to 2.17

 Confusion, memory loss

1.83

0.74 to 4.81

Mental health SPS

1.21

0.75 to 2.27

 Depressive symptoms

1.08

0.89 to1.28

 Anxiety symptoms

1.56

1.08 to 2.04

 Sleep disturbances

1.11

0.88 to 1.48

Dermatological SPS

0.44

0.19 to 1.00

Digestive SPS

0.28

0.13 to 0.62

  1. 1Only SPS with enough number of patients (>8 per group) were included in this analysis
Back to article page

BMC Medicine

ISSN: 1741-7015

Contact us